This site is intended for healthcare professionals

Mastering Cardiovascular and Hypertension Management: Expert Insights for Better Outcomes

Educational Activities

CME-accredited Video Interviews with Experts
CME-accredited Video Interviews with Experts
  • Key role of CV risk assessment and treatment strategies for the new category of patients introduced by 2024 ESC guidelines on hypertension
Release: 26/02/2026
30 min
0,5
Microlearning Video Episode 1
Microlearning Video Episode 1
  • Burden and risk assessment of CV complications (e.g. gestationalhypertension, arrhythmia, etc) occuring during pregnancy
Release: 09/04/2026
15 min
Microlearning Video Episode 2
Microlearning Video Episode 2
  • Drugs safety during pregnancy, with highlights from the new ESCguidelines that will be released late Aug25.
Release: 28/05/2026
15 min
CME-accredited Video Interviews with Experts
CME-accredited Video Interviews with Experts
  • Mental health disorders as independent risk factors for CVD (burden,mechanisms, etc)
  • After introducing mental health as non-traditional risk factor forhypertension (2024 ESC guidelines), in late Aug2025 ESC will release newguidelines upon mental disorders and CVD
Release: 25/06/2026
30 min
0,5
CME-accredited Video Interviews with Experts
CME-accredited Video Interviews with Experts
  • Characteristics of different types of hormone therapies (menopausal,transfeminine gender-affirming, transmasculine gender-affirming,procreation) and its correlation with CV risk
  • Management of CVD in patients receiving/received hormone therapies
Release: 24/09/2026
30 min
0,5
26/02/2026
Video Interview
30 min

0,5 CME credits (EACCME)

| CME Credits 

0,5
cardiology
Cardiovascular Diseases

Elevated Blood Pressure (BP)

  • Key role of CV risk assessment and treatment strategies for the new category of patients introduced by 2024 ESC guidelines on hypertension

Faculty

Angeloni Emiliano
Mahfoud Felix
Release: 26/02/2026
09/04/2026
Microlearning Video
15 min
cardiology
Cardiovascular Diseases

CVD and Pregnancy (A) Risk Assessment and Multidisciplinary Care

  • Burden and risk assessment of CV complications (e.g. gestationalhypertension, arrhythmia, etc) occuring during pregnancy

Faculty

Cifkova Renata
Release: 09/04/2026
28/05/2026
Microlearning Video
15 min
cardiology
Cardiovascular Diseases

CVD and Pregnancy (B) Drug Safety and ESC 2025 Updates

  • Drugs safety during pregnancy, with highlights from the new ESCguidelines that will be released late Aug25.

Faculty

Cifkova Renata
Release: 28/05/2026
25/06/2026
Video Interview
30 min

0,5 CME credits (EACCME)

| CME Credits 

0,5
cardiology
Cardiovascular Diseases

CVD and Mental Disorders

  • Mental health disorders as independent risk factors for CVD (burden,mechanisms, etc)
  • After introducing mental health as non-traditional risk factor forhypertension (2024 ESC guidelines), in late Aug2025 ESC will release newguidelines upon mental disorders and CVD

Faculty

Angeloni Emiliano
Coca Antonio
Release: 25/06/2026
24/09/2026
Video Interview
30 min

0,5 CME credits (EACCME)

| CME Credits 

0,5
cardiology
Cardiovascular Diseases

Hormone Therapies

  • Characteristics of different types of hormone therapies (menopausal,transfeminine gender-affirming, transmasculine gender-affirming,procreation) and its correlation with CV risk
  • Management of CVD in patients receiving/received hormone therapies

Faculty

Angeloni Emiliano
Tadic Marijana
Release: 24/09/2026

Despite the availability of numerous health education initiatives, lifestyle modification strategies, and pharmacological treatments, achieving effective and sustained reduction of elevated blood pressure (BP) remains a major global medical challenge. Hypertension is a leading risk factor for cardiovascular disease (CVD), significantly contributing to morbidity and mortality worldwide. The global burden of hypertension has increased dramatically, with the number of affected individuals aged 30–79 years doubling between 1990 and 2019. As a result, contemporary antihypertensive management is increasingly challenged by emerging and non-traditional clinical scenarios, including pregnancy, hormone therapies, and mental health disorders. This educational initiative has been developed to address critical, evidence-based gaps in knowledge and clinical competence among healthcare professionals involved in the management of cardiovascular disease and hypertension. By integrating multiple interactive and flexible learning formats with robust pre- and post-assessment tools, the program aims to promote both immediate learner engagement and sustained changes in clinical practice. To address current unmet educational needs in this evolving field, Scientific Seminars International Foundation (SSIF) proposes the present educational initiative, specifically designed to support healthcare professionals involved in the management of cardiovascular disease and hypertension disorders.

  • Accurately diagnose patients with elevated blood pressure and perform appropriate cardiovascular risk stratification to guide optimal medical management
  • Understand the burden and management of cardiovascular disease during pregnancy, with a particular focus on the appropriateness of pharmacological treatments in pregnant women and key recommendations from the 2025 ESC Guidelines on CVD management during pregnancy
  • Assess the role of mental disorders as cardiovascular risk factors, incorporating updated insights from the 2025 ESC Guidelines on mental health and cardiovascular disease
  • Identify and manage cardiovascular risk associated with hormone therapies, understanding their implications
    for blood pressure control and overall cardiovascular health

Cardiologists, Internal Medicine Specialists, General Practitioners

All activities will be in English.
The Video Interviews will be in English with subtitles in Chinese and Spanish

The Video Interviews will be submitted for CME accreditation by the EACCME.

Emiliano Angeloni
Emiliano Angeloni
Cardiovascular Pathophysiology and Imaging
Heart and Great Vessels Surgery
Valle Giulia Clinic
Rome, Italy

No results found.

Share it on social

EDUCATIONAL RESOURCES

For information about the programme, please contact:
Annamaria Nesticò | Senior Progamme Manager | annamaria.nestico@scientificseminars.com

This independent educational programme is made possible thanks to an unrestricted educational grant received from Merck Healthcare KGaA, Darmstadt, Germany.

Other activities

Scientific Seminars Foundation